Treanda
Product Images NDC 63459-395

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Treanda (NDC 63459-395). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cephalon, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

Chemical structure diagram of the active ingredient in TREANDA, showing its molecular framework with labeled functional groups and bonds.*

FDA Label Image

Figure 1. Progression-free Survival (Image 2)

A line graph titled 'Figure 1. Progression-Free Survival' compares survival distribution functions over months between study treatment and TREANDA. The x-axis represents progression-free survival in months, and the y-axis shows the survival distribution function, illustrating differences in progression-free survival between the two treatments over time.*

FDA Label Image

25 mg Carton (Image 3)

TREANDA 25 mg/vial (bendamustine HCl) for Injection single-use vial carton label. The label indicates it is sterile, for intravenous infusion only, requiring reconstitution and dilution. It includes storage instructions, cytotoxic agent warnings, and directions to discard unused portions. The label also lists the vial contents as 25 mg bendamustine HCl in 42.5 mg mannitol, manufactured by Cephalon, LLC and distributed by Teva Pharmaceuticals USA, Inc.*

FDA Label Image

100 mg Carton (Image 4)

TREANDA (bendamustine HCl) Injection 100 mg/vial packaging label by Cephalon, LLC. The label indicates it is a sterile, single-use vial for intravenous infusion only, requiring reconstitution and dilution. It includes storage instructions, cytotoxic agent warnings, and a barcode. Manufactured by Teva Pharmaceuticals USA, Inc.*

FDA Label Image

Packaging (Image 5)

TREANDA (bendamustine HCl) injection 45 mg/0.5 mL sterile vial label by Cephalon, LLC. The label indicates refrigeration storage at 2 to 8°C (36 to 46°F), protection from light, and single-dose vial use with discard instructions. It is intended for intravenous infusion only, requiring further dilution. The active ingredients and vial contents are specified, with warnings against using with devices containing polycarbonate or acrylonitrile butadiene-styrene (ABS).*

FDA Label Image

Packaging (Image 6)

TREANDA 180 mg/2 mL (90 mg/mL) injection label by Cephalon, LLC. Contains bendamustine HCl for intravenous infusion only. Single-dose vial with instructions to discard unused portion. Store refrigerated at 2 to 8°C, protect from light, and follow safety precautions marked as cytotoxic agent. Includes directions for use and warnings against use with devices containing polycarbonate or acrylonitrile butadiene-styrene (ABS).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.